Edwin Miranda Joins Cytovance Biologics

In January of 2018, Cytovance Biologics announced that they were hiring Edwin Miranda as their new Vice President of Quality. As a graduate of Angelo State University in San Angelo, Texas with a Bachelors of Science in Biology and Chemistry, Edwin Miranda has more than 33 years experience in the field of biopharmaceutical contract manufacturing, much of it in quality assurance for biologics companies.

Coming from such companies as Mutual Pharmaceuticals, Inc., Piramal Critical Care, Inc. and Legacy Pharmaceutical Packaging, Edwin Miranda is experienced not only in quality assurance but also with regulatory compliance and even developed a remediation plan to correct for hundreds of observations, for which he received a Establishment Inspection Report in good standing.

An army veteran, Edwin Miranda is positioned to help Cytovance Biologics with a slew of BLA’s in the 2018 year, something his regulatory compliance experience prepared him for. Described as an asset for the company by Senior Vice President of Research and Development Doctor Jesse McCool, Sr., Edwin Miranda is experienced in a wide range of industry niches, including biologics, cosmetics and liquid and solid oral doses.

Edwin Miranda also oversaw the quality assurance team at Keppra, assisting that company in their successful bid to get FDA approval for the New Drug Application, the formal final step for a drug manufacturer to attain approval to begin marketing a new drug, a prestigious role in an important regulatory accomplishment.

Cytovance Biologics specializes in biopharmaceutical contract manufacturing, producing antibodies and therapeutic proteins from both mammal cell cultures as well as microbial fermentation. They also offer assistance with process development, support services and cell banking services for other labs and companies. The company operates out of facilities in Oklahoma City, Oklahoma. They maintain state-of-the-art facilities and seem very excited to have Edwin Miranda join their team.

To Read More Click Here